Glass Health

Glass Health's pitch is that reasoning and documentation belong in one place, and the product is built that way. You ask a clinical question — about symptoms, labs, a medication, a diagnosis, or next steps — and the Glass clinical agent reasons across the full longitudinal record and returns recommendations tied to peer-reviewed literature rather than a bare model guess. The same agent writes the note: History & Physical, progress notes, discharge summaries, discharge instructions, and patient handouts. Strengths. The evidence grounding is the headline. Glass says responses are built around 38M+ peer-reviewed articles, 40M+ PubMed citations, clinical guidelines, and US FDA drug information, with inline citations a clinician can check. That matters more in clinical use than fluency. Second, the stated performance in the Harvard-Stanford ARISE NOHARM evaluation — a physician-validated clinical safety benchmark where Glass says it ranked ahead of systems from OpenAI and Anthropic — is the kind of third-party-style validation most scribing tools do not have. Third, the platform is genuinely two products in one: decision support (differential diagnosis, assessment and plan, chart summarization) and documentation (ambient scribing plus the note types above), which means one subscription and one workspace rather than a scribe plus a reference tool. Fourth, the Glass Developer API lets healthcare product teams embed reasoning and scribing, and Glass for Patients extends record navigation to patients. Weaknesses and things to verify. The company's public material does not enumerate specific EHR integrations, so if your workflow depends on chart context flowing automatically from a particular EHR, treat that as a scoping question for Glass and your EHR team rather than something the site settles. Documentation quality and template fit vary by specialty, so a single-site or single-cohort pilot is the sensible first step. And the platform is aimed at clinicians — Glass for Patients is described as health-record navigation, not triage, so it is not a consumer symptom checker. Where it fits. Clinicians and specialists who want an evidence-cited answer and a finished note without context-switching; residents, NPs, and PAs building a differential at the point of care; practices and health systems trying to reduce documentation burden across MDs, PAs, and PharmDs; and complex or value-based care settings where guideline-grounded reasoning is the point of the purchase rather than speed. It also fits healthcare product teams that want clinical reasoning as an API rather than a build-it-yourself project. Where it doesn't. If all you need is cheap transcription with no clinical reasoning attached, you are paying for capability you won't use. If your rollout plan can't accommodate a data-governance review, a BAA, and access-control decisions for PHI, the pilot will stall before it starts.